Acorda Therapeutics
Anthony Michael is an accomplished legal professional with extensive experience in litigation management within the biotechnology sector. Serving as the Executive Director of Litigation at Acorda Therapeutics, Inc. since September 2013, Anthony oversees all litigation activities and provides strategic advice on intellectual property and regulatory matters. Prior to this role, Anthony held positions at Paul Hastings LLP and Kaye Scholer LLP, where responsibilities included developing patent strategies and supervising pre-trial processes. Educational qualifications include a Doctor of Law (JD) from Rutgers Law School and a Bachelor of Science (BS) in Biotechnology from Rutgers University.
This person is not in the org chart
This person is not in any teams
Acorda Therapeutics
1 followers
Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.